Press Releases from Datavagyanik Business Intelligence (547 total)
Beta-Sitosterol Supplements Market Size, Clinical Trials, Product Pipelines and …
Beta-Sitosterol Supplements Market Size is estimated to be $670 million in 2024 and is expected to grow at an average yearly rate of around…
Cranberry-based Supplements Market Size, Clinical Trials, Product Pipelines and …
Cranberry-based Supplements Market Size is estimated to be $1040 million in 2024 and is expected to grow at an average yearly rate of around 8%…
Lipase Inhibitors Market Size, Clinical Trials, Product Pipelines and Investment …
Lipase Inhibitors Market Size is estimated to be $945 million in 2024 and is expected to grow at an average yearly rate of around 6%…
Tricyclic Antidepressants Market Size, Clinical Trials, Product Pipelines and In …
Tricyclic Antidepressants Market Size is estimated to be $4950 million in 2024 and is expected to grow at an average yearly rate of around…
Antibody Drug Conjugates for Breast Cancer Market Size, Clinical Trials, Product …
Antibody Drug Conjugates for Breast Cancer Market Size is estimated to be $2570 million in 2024 and is expected to grow at an average yearly…
Nectin-4-targeted Antibody Drug Conjugates Market Size, Clinical Trials, Product …
Nectin-4-targeted Antibody Drug Conjugates Market Size is estimated to be $2410 million in 2024 and is expected to grow at an average yearly rate of…
CD30-targeted Antibody Drug Conjugates Market Size, Clinical Trials, Product Pip …
CD30-targeted Antibody Drug Conjugates Market Size is estimated to be $3560 million in 2024 and is expected to grow at an average yearly rate of…
HER2-targeted Antibody Drug Conjugates Market Size, Clinical Trials, Product Pip …
HER2-targeted Antibody Drug Conjugates Market Size is estimated to be $7650 million in 2024 and is expected to grow at an average yearly rate of…
Immune Checkpoint Inhibitors for Melanoma Treatment Market Size, Clinical Trials …
Immune Checkpoint Inhibitors for Melanoma Treatment Market Size is estimated to be $9250 million in 2024 and is expected to grow at an average yearly…
CTLA-4 Inhibitors (Cytotoxic T-Lymphocyte-Associated Protein 4 Inhibitors) Marke …
CTLA-4 Inhibitors (Cytotoxic T-Lymphocyte-Associated Protein 4 Inhibitors) Market Size is estimated to be $2150 million in 2024 and is expected to grow at an average…
Cold Agglutinin Disease Therapeutics Market Size, Clinical Trials, Product Pipel …
Cold Agglutinin Disease Therapeutics Market Size is estimated to be $62 million in 2024 and is expected to grow at an average yearly rate of…
Warm Autoimmune Hemolytic Anemia Treatment Market Size, Clinical Trials, Product …
Warm Autoimmune Hemolytic Anemia Treatment Market Size is estimated to be $570 million in 2024 and is expected to grow at an average yearly rate…
Particle Therapy for Lung Cancer Market Size, Clinical Trials, Product Pipelines …
Particle Therapy for Lung Cancer Market Size is estimated to be $185 million in 2024 and is expected to grow at an average yearly rate…
Particle Therapy for Prostate Cancer Market Size, Clinical Trials, Product Pipel …
Particle Therapy for Prostate Cancer Market Size is estimated to be $320 million in 2024 and is expected to grow at an average yearly rate…
Platelet-Rich Plasma (PRP) Injections for Osteoarthritis Market Size, Clinical T …
Platelet-Rich Plasma (PRP) Injections for Osteoarthritis Market Size is estimated to be $520 million in 2024 and is expected to grow at an average yearly…
Hyaluronic Acid (HA) Injectable Therapies for Osteoarthritis Market Size, Clinic …
Hyaluronic Acid (HA) Injectable Therapies for Osteoarthritis Market Size is estimated to be $2950 million in 2024 and is expected to grow at an average…
Metronidazole-Based Antibiotics Market Size, Clinical Trials, Product Pipelines …
Metronidazole-Based Antibiotics Market Size is estimated to be $1415 million in 2024 and is expected to grow at an average yearly rate of around 4%…
Chlorhexidine Antimicrobial Agents Market Size, Clinical Trials, Product Pipelin …
Chlorhexidine Antimicrobial Agents Market Size is estimated to be $170 million in 2024 and is expected to grow at an average yearly rate of around…
Nodular Basal Cell Carcinoma Treatment Market Size, Clinical Trials, Product Pip …
Nodular Basal Cell Carcinoma Treatment Market Size is estimated to be $5100 million in 2024 and is expected to grow at an average yearly rate…
Dupixent for Moderate-to-Severe Asthma Treatment Market Size, Clinical Trials, P …
Dupixent for Moderate-to-Severe Asthma Treatment Market Size is estimated to be $3250 million in 2024 and is expected to grow at an average yearly rate…
Integrin Inhibitors Market Size, Clinical Trials, Product Pipelines and Investme …
Integrin Inhibitors Market Size is estimated to be $2150 million in 2024 and is expected to grow at an average yearly rate of around 6%…
Monoclonal Antibody Therapies for Connective Tissue Diseases Market Size, Clinic …
Monoclonal Antibody Therapies for Connective Tissue Diseases Market Size is estimated to be $6850 million in 2024 and is expected to grow at an average…
Immunosuppressive Drugs for Connective Tissue Diseases Market Size, Clinical Tri …
Immunosuppressive Drugs for Connective Tissue Diseases Market Size is estimated to be $5250 million in 2024 and is expected to grow at an average yearly…
Oral Naltrexone for Alcohol and Opioid Dependence Market Size, Clinical Trials, …
Oral Naltrexone for Alcohol and Opioid Dependence Market Size is estimated to be $920 million in 2024 and is expected to grow at an average…
Long-acting Buprenorphine Injectables Market Size, Clinical Trials, Product Pipe …
Long-acting Buprenorphine Injectables Market Size is estimated to be $2010 million in 2024 and is expected to grow at an average yearly rate of…
Desmopressin-based Coagulation Therapy Market Size, Clinical Trials, Product Pip …
Desmopressin-based Coagulation Therapy Market Size is estimated to be $380 million in 2024 and is expected to grow at an average yearly rate of around…
Topical Hemostatic Agents Market Size, Clinical Trials, Product Pipelines and In …
Topical Hemostatic Agents Market Size is estimated to be $3010 million in 2024 and is expected to grow at an average yearly rate of around…
Vitamin K-based Coagulants Market Size, Clinical Trials, Product Pipelines and I …
Vitamin K-based Coagulants Market Size is estimated to be $580 million in 2024 and is expected to grow at an average yearly rate of…
Typhoid Conjugate Vaccines Market Size, Clinical Trials, Product Pipelines and I …
Typhoid Conjugate Vaccines Market Size is estimated to be $262 million in 2024 and is expected to grow at an average yearly rate of around…
Meningococcal Conjugate Vaccines Market Size, Clinical Trials, Product Pipelines …
Meningococcal Conjugate Vaccines Market Size is estimated to be $3250 million in 2024 and is expected to grow at an average yearly rate of around…
Transdermal Contraceptive Patches Market Size, Clinical Trials, Product Pipeline …
Transdermal Contraceptive Patches Market Size is estimated to be $800 million in 2024 and is expected to grow at an average yearly rate of around…
Long-Acting Injectable Contraceptives Market Size, Clinical Trials, Product Pipe …
Long-Acting Injectable Contraceptives Market Size is estimated to be $708 million in 2024 and is expected to grow at an average yearly rate of around…
Anticholinergic Drugs for Urinary Incontinence Market Size, Clinical Trials, Pro …
Anticholinergic Drugs for Urinary Incontinence Market Size is estimated to be $2950 million in 2024 and is expected to grow at an average yearly rate…
Therapies for Sarcopenia (Age-related Muscle Loss) Market Size, Clinical Trials, …
Therapies for Sarcopenia (Age-related Muscle Loss) Market Size is estimated to be $3100 million in 2024 and is expected to grow at an average yearly…
Rapid-Acting Insulin Analogs Market Size, Clinical Trials, Product Pipelines and …
Rapid-Acting Insulin Analogs Market Size is estimated to be $7120 million in 2024 and is expected to grow at an average yearly rate of around…
Monoclonal Antibody Therapies for Multiple Myeloma Market Size, Clinical Trials, …
Monoclonal Antibody Therapies for Multiple Myeloma Market Size is estimated to be $3265 million in 2024 and is expected to grow at an average yearly…
Immunomodulatory Drugs (IMiDs) for Multiple Myeloma Market Size, Clinical Trials …
Immunomodulatory Drugs (IMiDs) for Multiple Myeloma Market Size is estimated to be $3160 million in 2024 and is expected to grow at an average yearly…
Proteasome Inhibitors for Multiple Myeloma Market Size, Clinical Trials, Product …
Proteasome Inhibitors for Multiple Myeloma Market Size is estimated to be $2350 million in 2024 and is expected to grow at an average yearly rate…
Immunosuppressive agents Market Size, Clinical Trials, Product Pipelines and Inv …
Immunosuppressive agents Market Size is estimated to be $18650 million in 2024 and is expected to grow at an average yearly rate of around 14%…
Corticosteroid Eye Drops for Anterior Uveitis Market Size, Clinical Trials, Prod …
Corticosteroid Eye Drops for Anterior Uveitis Market Size is estimated to be $1560 million in 2024 and is expected to grow at an average yearly…
Enzyme Replacement Therapy (ERT) for Fabry Disease Market Size, Clinical Trials, …
Enzyme Replacement Therapy (ERT) for Fabry Disease Market Size is estimated to be $1950 million in 2024 and is expected to grow at an average…
Interleukin (IL)-12/23 Inhibitors for Crohn's Disease Market Size, Clinical Tria …
Interleukin (IL)-12/23 Inhibitors for Crohn's Disease Market Size is estimated to be $4150 million in 2024 and is expected to grow at an average yearly…
TNF-alpha Inhibitors for Crohn's Disease Market Size, Clinical Trials, Product P …
TNF-alpha Inhibitors for Crohn's Disease Market Size is estimated to be $12500 million in 2024 and is expected to grow at an average yearly rate…
Direct-Acting Antiviral (DAA) Therapies for Hepatitis C Market Size, Clinical Tr …
Direct-Acting Antiviral (DAA) Therapies for Hepatitis C Market Size is estimated to be $8250 million in 2024 and is expected to grow at an average…
PI3K Inhibitors for Breast Adenocarcinoma Market Size, Clinical Trials, Product …
PI3K Inhibitors for Breast Adenocarcinoma Market Size is estimated to be $330 million in 2024 and is expected to grow at an average yearly rate…
PARP Inhibitors for Breast Adenocarcinoma Market Size, Clinical Trials, Product …
PARP Inhibitors for Breast Adenocarcinoma Market Size is estimated to be $1740 million in 2024 and is expected to grow at an average yearly rate…
Hormonal (Endocrine) Therapies for Breast Adenocarcinoma Market Size, Clinical T …
Hormonal (Endocrine) Therapies for Breast Adenocarcinoma Market Size is estimated to be $12400 million in 2024 and is expected to grow at an average yearly…
CDK4/6 Inhibitors for Breast Adenocarcinoma Market Size, Clinical Trials, Produc …
CDK4/6 Inhibitors for Breast Adenocarcinoma Market Size is estimated to be $8250 million in 2024 and is expected to grow at an average yearly rate…
HER2-Targeted Therapies for Breast Adenocarcinoma Market Size, Clinical Trials, …
HER2-Targeted Therapies for Breast Adenocarcinoma Market Size is estimated to be $13500 million in 2024 and is expected to grow at an average yearly rate…
Radioactive Iodine Therapy for Thyroid Gland Disorders Market Size, Clinical Tri …
Radioactive Iodine Therapy for Thyroid Gland Disorders Market Size is estimated to be $390 million in 2024 and is expected to grow at an average…
